Hemodynamic effects of carvedilol plus simvastatin in cirrhosis with severe portal hypertension and suboptimal response to β-blockers: A double-blind, placebo-controlled, randomized-trial

已完结 20 由 han 发布于 2025/2/24 9:18:26

DOI:10.1097/hep.0000000000001148
作者：Edilmar Alvarado-Tapias, Anna Brujats, Angela Puente, Alba Ardevol, Ainhoa Rodriguez-Arias, Javier Fajardo, Oanna Pavel, Marta Garcia-Guix, Carles Aracil, Maria Poca, Berta Cuyàs, Elisabet Cantó, Ro
文献类型：期刊论文
补充材料：只需要正文

Wolters Kluwer Ovid

Abstract：Background Aims: Carvedilol is a non-selective β-blocker (NSBBs) with anti-α1-adrenergic activity, more effective than traditional NSBBs in reducing portal-pressure (HVPG). However, 35%-45%

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:Frontiers MediaAll-Optical Polarization Manipulation Through Orbital Polarization Holography